Pre-order Enquiry
Request Free Sample
Global and China Human Interleukin-2 (IL-2) Market Insights, Forecast to 2027
SKU ID : QYR-19208997 | Publishing Date : 23-Sep-2021 | No. of pages : 168
Detailed TOC of Global and China Human Interleukin-2 (IL-2) Market Insights, Forecast to 2027
1 Study Coverage1.1 Human Interleukin-2 (IL-2) Product Introduction
1.2 Market by Type
1.2.1 Global Human Interleukin-2 (IL-2) Market Size Growth Rate by Type
1.2.2 50000 U
1.2.3 100000 U
1.2.4 200000 U
1.2.5 500000 U
1.2.6 1 Million U
1.2.7 2 Million U
1.3 Market by Application
1.3.1 Global Human Interleukin-2 (IL-2) Market Size Growth Rate by Application
1.3.2 Recombinant Interferon
1.3.3 Recombinant Interleukin
1.3.4 Natural Biological Products
1.3.5 Poison Immune
1.3.6 Gene Therapy
1.3.7 Monoclonal Antibody
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Interleukin-2 (IL-2) Market Size, Estimates and Forecasts
2.1.1 Global Human Interleukin-2 (IL-2) Revenue 2016-2027
2.1.2 Global Human Interleukin-2 (IL-2) Sales 2016-2027
2.2 Global Human Interleukin-2 (IL-2), Market Size by Region: 2016 VS 2021 VS 2027
2.3 Human Interleukin-2 (IL-2) Historical Market Size by Region (2016-2021)
2.3.1 Global Human Interleukin-2 (IL-2) Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Human Interleukin-2 (IL-2) Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Human Interleukin-2 (IL-2) Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Human Interleukin-2 (IL-2) Sales Forecast by Region (2022-2027)
2.4.2 Global Human Interleukin-2 (IL-2) Revenue Forecast by Region (2022-2027)
3 Global Human Interleukin-2 (IL-2) Competitor Landscape by Players
3.1 Global Top Human Interleukin-2 (IL-2) Manufacturers by Sales
3.1.1 Global Human Interleukin-2 (IL-2) Sales by Manufacturer (2016-2021)
3.1.2 Global Human Interleukin-2 (IL-2) Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Human Interleukin-2 (IL-2) Manufacturers by Revenue
3.2.1 Key Human Interleukin-2 (IL-2) Manufacturers Covered: Ranking by Revenue
3.2.2 Global Human Interleukin-2 (IL-2) Revenue by Manufacturers (2016-2021)
3.2.3 Global Human Interleukin-2 (IL-2) Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Human Interleukin-2 (IL-2) Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Human Interleukin-2 (IL-2) Revenue in 2020
3.2.6 Global Human Interleukin-2 (IL-2) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Human Interleukin-2 (IL-2) Price by Manufacturers
3.4 Global Human Interleukin-2 (IL-2) Manufacturing Base Distribution, Product Types
3.4.1 Human Interleukin-2 (IL-2) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Interleukin-2 (IL-2) Product Type
3.4.3 Date of International Manufacturers Enter into Human Interleukin-2 (IL-2) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Human Interleukin-2 (IL-2) Market Size by Type (2016-2021)
4.1.1 Global Human Interleukin-2 (IL-2) Sales by Type (2016-2021)
4.1.2 Global Human Interleukin-2 (IL-2) Revenue by Type (2016-2021)
4.1.3 Human Interleukin-2 (IL-2) Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Human Interleukin-2 (IL-2) Market Size Forecast by Type (2022-2027)
4.2.1 Global Human Interleukin-2 (IL-2) Sales Forecast by Type (2022-2027)
4.2.2 Global Human Interleukin-2 (IL-2) Revenue Forecast by Type (2022-2027)
4.2.3 Human Interleukin-2 (IL-2) Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Human Interleukin-2 (IL-2) Market Size by Application (2016-2021)
5.1.1 Global Human Interleukin-2 (IL-2) Sales by Application (2016-2021)
5.1.2 Global Human Interleukin-2 (IL-2) Revenue by Application (2016-2021)
5.1.3 Human Interleukin-2 (IL-2) Price by Application (2016-2021)
5.2 Human Interleukin-2 (IL-2) Market Size Forecast by Application (2022-2027)
5.2.1 Global Human Interleukin-2 (IL-2) Sales Forecast by Application (2022-2027)
5.2.2 Global Human Interleukin-2 (IL-2) Revenue Forecast by Application (2022-2027)
5.2.3 Global Human Interleukin-2 (IL-2) Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Human Interleukin-2 (IL-2) Market Size YoY Growth 2016-2027
6.1.1 China Human Interleukin-2 (IL-2) Sales YoY Growth 2016-2027
6.1.2 China Human Interleukin-2 (IL-2) Revenue YoY Growth 2016-2027
6.1.3 China Human Interleukin-2 (IL-2) Market Share in Global Market 2016-2027
6.2 China Human Interleukin-2 (IL-2) Market Size by Players (International and Local Players)
6.2.1 China Top Human Interleukin-2 (IL-2) Players by Sales (2016-2021)
6.2.2 China Top Human Interleukin-2 (IL-2) Players by Revenue (2016-2021)
6.3 China Human Interleukin-2 (IL-2) Historic Market Review by Type (2016-2021)
6.3.1 China Human Interleukin-2 (IL-2) Sales Market Share by Type (2016-2021)
6.3.2 China Human Interleukin-2 (IL-2) Revenue Market Share by Type (2016-2021)
6.3.3 China Human Interleukin-2 (IL-2) Price by Type (2016-2021)
6.4 China Human Interleukin-2 (IL-2) Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Human Interleukin-2 (IL-2) Sales Forecast by Type (2022-2027)
6.4.2 China Human Interleukin-2 (IL-2) Revenue Forecast by Type (2022-2027)
6.4.3 China Human Interleukin-2 (IL-2) Price Forecast by Type (2022-2027)
6.5 China Human Interleukin-2 (IL-2) Historic Market Review by Application (2016-2021)
6.5.1 China Human Interleukin-2 (IL-2) Sales Market Share by Application (2016-2021)
6.5.2 China Human Interleukin-2 (IL-2) Revenue Market Share by Application (2016-2021)
6.5.3 China Human Interleukin-2 (IL-2) Price by Application (2016-2021)
6.6 China Human Interleukin-2 (IL-2) Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Human Interleukin-2 (IL-2) Sales Forecast by Application (2022-2027)
6.6.2 China Human Interleukin-2 (IL-2) Revenue Forecast by Application (2022-2027)
6.6.3 China Human Interleukin-2 (IL-2) Price Forecast by Application (2022-2027)
7 North America
7.1 North America Human Interleukin-2 (IL-2) Market Size YoY Growth 2016-2027
7.2 North America Human Interleukin-2 (IL-2) Market Facts & Figures by Country
7.2.1 North America Human Interleukin-2 (IL-2) Sales by Country (2016-2021)
7.2.2 North America Human Interleukin-2 (IL-2) Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Human Interleukin-2 (IL-2) Market Size YoY Growth 2016-2027
8.2 Asia Pacific Human Interleukin-2 (IL-2) Market Facts & Figures by Region
8.2.1 Asia Pacific Human Interleukin-2 (IL-2) Sales by Region (2016-2021)
8.2.2 Asia Pacific Human Interleukin-2 (IL-2) Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Human Interleukin-2 (IL-2) Market Size YoY Growth 2016-2027
9.2 Europe Human Interleukin-2 (IL-2) Market Facts & Figures by Country
9.2.1 Europe Human Interleukin-2 (IL-2) Sales by Country (2016-2021)
9.2.2 Europe Human Interleukin-2 (IL-2) Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Human Interleukin-2 (IL-2) Market Size YoY Growth 2016-2027
10.2 Latin America Human Interleukin-2 (IL-2) Market Facts & Figures by Country
10.2.1 Latin America Human Interleukin-2 (IL-2) Sales by Country (2016-2021)
10.2.2 Latin America Human Interleukin-2 (IL-2) Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Human Interleukin-2 (IL-2) Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Human Interleukin-2 (IL-2) Market Facts & Figures by Country
11.2.1 Middle East and Africa Human Interleukin-2 (IL-2) Sales by Country (2016-2021)
11.2.2 Middle East and Africa Human Interleukin-2 (IL-2) Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Description and Business Overview
12.1.3 Roche Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Human Interleukin-2 (IL-2) Products Offered
12.1.5 Roche Recent Development
12.2 BMS
12.2.1 BMS Corporation Information
12.2.2 BMS Description and Business Overview
12.2.3 BMS Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 BMS Human Interleukin-2 (IL-2) Products Offered
12.2.5 BMS Recent Development
12.3 Schering-Plough
12.3.1 Schering-Plough Corporation Information
12.3.2 Schering-Plough Description and Business Overview
12.3.3 Schering-Plough Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Schering-Plough Human Interleukin-2 (IL-2) Products Offered
12.3.5 Schering-Plough Recent Development
12.4 AbbVie Inc
12.4.1 AbbVie Inc Corporation Information
12.4.2 AbbVie Inc Description and Business Overview
12.4.3 AbbVie Inc Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 AbbVie Inc Human Interleukin-2 (IL-2) Products Offered
12.4.5 AbbVie Inc Recent Development
12.5 Alkermes Plc
12.5.1 Alkermes Plc Corporation Information
12.5.2 Alkermes Plc Description and Business Overview
12.5.3 Alkermes Plc Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Alkermes Plc Human Interleukin-2 (IL-2) Products Offered
12.5.5 Alkermes Plc Recent Development
12.6 APT Therapeutics
12.6.1 APT Therapeutics Corporation Information
12.6.2 APT Therapeutics Description and Business Overview
12.6.3 APT Therapeutics Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 APT Therapeutics Human Interleukin-2 (IL-2) Products Offered
12.6.5 APT Therapeutics Recent Development
12.7 Mabtech Limited
12.7.1 Mabtech Limited Corporation Information
12.7.2 Mabtech Limited Description and Business Overview
12.7.3 Mabtech Limited Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Mabtech Limited Human Interleukin-2 (IL-2) Products Offered
12.7.5 Mabtech Limited Recent Development
12.8 Philogen
12.8.1 Philogen Corporation Information
12.8.2 Philogen Description and Business Overview
12.8.3 Philogen Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Philogen Human Interleukin-2 (IL-2) Products Offered
12.8.5 Philogen Recent Development
12.9 Sinopharm
12.9.1 Sinopharm Corporation Information
12.9.2 Sinopharm Description and Business Overview
12.9.3 Sinopharm Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Sinopharm Human Interleukin-2 (IL-2) Products Offered
12.9.5 Sinopharm Recent Development
12.10 Jiangsu Jinsili Pharmaceutical
12.10.1 Jiangsu Jinsili Pharmaceutical Corporation Information
12.10.2 Jiangsu Jinsili Pharmaceutical Description and Business Overview
12.10.3 Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Products Offered
12.10.5 Jiangsu Jinsili Pharmaceutical Recent Development
12.11 Roche
12.11.1 Roche Corporation Information
12.11.2 Roche Description and Business Overview
12.11.3 Roche Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Roche Human Interleukin-2 (IL-2) Products Offered
12.11.5 Roche Recent Development
12.12 Beijing Shuanglu Pharmaceutical
12.12.1 Beijing Shuanglu Pharmaceutical Corporation Information
12.12.2 Beijing Shuanglu Pharmaceutical Description and Business Overview
12.12.3 Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Beijing Shuanglu Pharmaceutical Products Offered
12.12.5 Beijing Shuanglu Pharmaceutical Recent Development
12.13 Shandong Quangang Pharmaceutical
12.13.1 Shandong Quangang Pharmaceutical Corporation Information
12.13.2 Shandong Quangang Pharmaceutical Description and Business Overview
12.13.3 Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Shandong Quangang Pharmaceutical Products Offered
12.13.5 Shandong Quangang Pharmaceutical Recent Development
12.14 Shanghai Huaxin Biological high-tech
12.14.1 Shanghai Huaxin Biological high-tech Corporation Information
12.14.2 Shanghai Huaxin Biological high-tech Description and Business Overview
12.14.3 Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Shanghai Huaxin Biological high-tech Products Offered
12.14.5 Shanghai Huaxin Biological high-tech Recent Development
12.15 Beijing Yuance Pharmaceutical
12.15.1 Beijing Yuance Pharmaceutical Corporation Information
12.15.2 Beijing Yuance Pharmaceutical Description and Business Overview
12.15.3 Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Beijing Yuance Pharmaceutical Products Offered
12.15.5 Beijing Yuance Pharmaceutical Recent Development
12.16 Beijing Sihuan Biological Pharmaceutical
12.16.1 Beijing Sihuan Biological Pharmaceutical Corporation Information
12.16.2 Beijing Sihuan Biological Pharmaceutical Description and Business Overview
12.16.3 Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Beijing Sihuan Biological Pharmaceutical Products Offered
12.16.5 Beijing Sihuan Biological Pharmaceutical Recent Development
12.17 Beijing Sanyuan Gene Pharmaceutical
12.17.1 Beijing Sanyuan Gene Pharmaceutical Corporation Information
12.17.2 Beijing Sanyuan Gene Pharmaceutical Description and Business Overview
12.17.3 Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Beijing Sanyuan Gene Pharmaceutical Products Offered
12.17.5 Beijing Sanyuan Gene Pharmaceutical Recent Development
12.18 Shenzhen Kexing Biological Engineering
12.18.1 Shenzhen Kexing Biological Engineering Corporation Information
12.18.2 Shenzhen Kexing Biological Engineering Description and Business Overview
12.18.3 Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Shenzhen Kexing Biological Engineering Products Offered
12.18.5 Shenzhen Kexing Biological Engineering Recent Development
12.19 Shanghai Sanwei Biotechnology
12.19.1 Shanghai Sanwei Biotechnology Corporation Information
12.19.2 Shanghai Sanwei Biotechnology Description and Business Overview
12.19.3 Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Shanghai Sanwei Biotechnology Products Offered
12.19.5 Shanghai Sanwei Biotechnology Recent Development
12.20 Xiamen Tebao Biological Engineering
12.20.1 Xiamen Tebao Biological Engineering Corporation Information
12.20.2 Xiamen Tebao Biological Engineering Description and Business Overview
12.20.3 Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Xiamen Tebao Biological Engineering Products Offered
12.20.5 Xiamen Tebao Biological Engineering Recent Development
12.21 Chengdu huashen Biotechnology
12.21.1 Chengdu huashen Biotechnology Corporation Information
12.21.2 Chengdu huashen Biotechnology Description and Business Overview
12.21.3 Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Chengdu huashen Biotechnology Products Offered
12.21.5 Chengdu huashen Biotechnology Recent Development
12.22 Shanghai Pharma Group
12.22.1 Shanghai Pharma Group Corporation Information
12.22.2 Shanghai Pharma Group Description and Business Overview
12.22.3 Shanghai Pharma Group Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Shanghai Pharma Group Products Offered
12.22.5 Shanghai Pharma Group Recent Development
12.23 Guangdong Xinghao Pharmaceutical
12.23.1 Guangdong Xinghao Pharmaceutical Corporation Information
12.23.2 Guangdong Xinghao Pharmaceutical Description and Business Overview
12.23.3 Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Guangdong Xinghao Pharmaceutical Products Offered
12.23.5 Guangdong Xinghao Pharmaceutical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Human Interleukin-2 (IL-2) Industry Trends
13.2 Human Interleukin-2 (IL-2) Market Drivers
13.3 Human Interleukin-2 (IL-2) Market Challenges
13.4 Human Interleukin-2 (IL-2) Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Interleukin-2 (IL-2) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and China Human Interleukin-2 (IL-2) Market Insights, Forecast to 2027
List of TablesTable 1. Global Human Interleukin-2 (IL-2) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 50000 U
Table 3. Major Manufacturers of 100000 U
Table 4. Major Manufacturers of 200000 U
Table 5. Major Manufacturers of 500000 U
Table 6. Major Manufacturers of 1 Million U
Table 7. Major Manufacturers of 2 Million U
Table 8. Global Human Interleukin-2 (IL-2) Market Size Growth Rate by Application (2021-2027) & (KG)
Table 9. Global Human Interleukin-2 (IL-2) Market Size by Region (KG) & (US$ Million), 2016 VS 2021 VS 2027
Table 10. Global Human Interleukin-2 (IL-2) Sales by Regions (2016-2021) & (KG)
Table 11. Global Human Interleukin-2 (IL-2) Sales Market Share by Regions (2016-2021)
Table 12. Global Human Interleukin-2 (IL-2) Revenue by Regions (2016-2021) & (US$ Million)
Table 13. Global Human Interleukin-2 (IL-2) Sales Forecast by Region (2022-2027) & (KG)
Table 14. Global Human Interleukin-2 (IL-2) Sales Market Share Forecast by Region (2022-2027)
Table 15. Global Human Interleukin-2 (IL-2) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 16. Global Human Interleukin-2 (IL-2) Revenue Market Share Forecast by Region (2022-2027)
Table 17. Global Human Interleukin-2 (IL-2) Sales by Manufacturers (2016-2021) (KG)
Table 18. Global Human Interleukin-2 (IL-2) Sales Share by Manufacturers (2016-2021)
Table 19. Ranking of Global Top Human Interleukin-2 (IL-2) Manufacturers by Revenue (US$ Million) in 2020
Table 20. Human Interleukin-2 (IL-2) Revenue by Manufacturers (2016-2021) (US$ Million)
Table 21. Human Interleukin-2 (IL-2) Revenue Share by Manufacturers (2016-2021)
Table 22. Global Human Interleukin-2 (IL-2) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 23. Global Human Interleukin-2 (IL-2) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Interleukin-2 (IL-2) as of 2020)
Table 24. Key Manufacturers Human Interleukin-2 (IL-2) Price (2016-2021) (US$/G)
Table 25. Human Interleukin-2 (IL-2) Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Human Interleukin-2 (IL-2) Product Type
Table 27. Date of International Manufacturers Enter into Human Interleukin-2 (IL-2) Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Human Interleukin-2 (IL-2) Sales by Type (2016-2021) (KG)
Table 30. Global Human Interleukin-2 (IL-2) Sales Share by Type (2016-2021)
Table 31. Global Human Interleukin-2 (IL-2) Revenue by Type (2016-2021) (US$ Million)
Table 32. Global Human Interleukin-2 (IL-2) Revenue Share by Type (2016-2021)
Table 33. Human Interleukin-2 (IL-2) Average Selling Price (ASP) by Type (2016-2021) & (US$/G)
Table 34. Global Human Interleukin-2 (IL-2) Sales Forecast by Type (2022-2027) & (KG)
Table 35. Global Human Interleukin-2 (IL-2) Sales Market Share Forecast by Type (2022-2027)
Table 36. Global Human Interleukin-2 (IL-2) Revenue Forecast V (2022-2027) & (US$ Million)
Table 37. Global Human Interleukin-2 (IL-2) Revenue Market Share Forecast by Type (2022-2027)
Table 38. Global Human Interleukin-2 (IL-2) Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/G)
Table 39. Global Human Interleukin-2 (IL-2) Sales by Application (2016-2021) (KG)
Table 40. Global Human Interleukin-2 (IL-2) Sales Share by Application (2016-2021)
Table 41. Global Human Interleukin-2 (IL-2) Revenue by Application (2016-2021) (US$ Million)
Table 42. Global Human Interleukin-2 (IL-2) Revenue Share by Application (2016-2021)
Table 43. Human Interleukin-2 (IL-2) Average Selling Price (ASP) by Application (2016-2021) & (US$/G)
Table 44. Global Human Interleukin-2 (IL-2) Sales Forecast by Application (2022-2027) & (KG)
Table 45. Global Human Interleukin-2 (IL-2) Sales Market Share Forecast by Application (2022-2027)
Table 46. Global Human Interleukin-2 (IL-2) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 47. Global Human Interleukin-2 (IL-2) Revenue Market Share Forecast by Application (2022-2027)
Table 48. Global Human Interleukin-2 (IL-2) Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/G)
Table 49. China Human Interleukin-2 (IL-2) Sales (KG) of Key Companies (2016-2021)
Table 50. China Human Interleukin-2 (IL-2) Sales Share by Company (2016-2021)
Table 51. China Human Interleukin-2 (IL-2) Revenue (US$ Million) by Company (2016-2021)
Table 52. China Human Interleukin-2 (IL-2) Revenue Share by Company (2016-2021)
Table 53. China Human Interleukin-2 (IL-2) Sales (KG) by Type (2016-2021)
Table 54. China Human Interleukin-2 (IL-2) Sales Share by Type (2016-2021)
Table 55. China Human Interleukin-2 (IL-2) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 56. China Human Interleukin-2 (IL-2) Price (US$/G) by Type (2016-2021)
Table 57. China Human Interleukin-2 (IL-2) Sales (KG) by Type (2022-2027)
Table 58. China Human Interleukin-2 (IL-2) Sales Share by Type (2022-2027)
Table 59. China Human Interleukin-2 (IL-2) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 60. China Human Interleukin-2 (IL-2) Revenue Share by Type (2022-2027)
Table 61. China Human Interleukin-2 (IL-2) Price (US$/G) by Type (2022-2027)
Table 62. China Human Interleukin-2 (IL-2) Sales (KG) by Application (2016-2021)
Table 63. China Human Interleukin-2 (IL-2) Sales Share by Application (2016-2021)
Table 64. China Human Interleukin-2 (IL-2) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 65. China Human Interleukin-2 (IL-2) Price (US$/G) by Application (2016-2021)
Table 66. China Human Interleukin-2 (IL-2) Sales (KG) by Application (2022-2027)
Table 67. China Human Interleukin-2 (IL-2) Sales Share by Application (2022-2027)
Table 68. China Human Interleukin-2 (IL-2) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 69. China Human Interleukin-2 (IL-2) Revenue Share by Application (2022-2027)
Table 70. China Human Interleukin-2 (IL-2) Price (US$/G) by Application (2022-2027)
Table 71. North America Human Interleukin-2 (IL-2) Sales by Country (2016-2021) & (KG)
Table 72. North America Human Interleukin-2 (IL-2) Sales Market Share by Country (2016-2021)
Table 73. North America Human Interleukin-2 (IL-2) Revenue by Country (2016-2021) & (US$ Million)
Table 74. North America Human Interleukin-2 (IL-2) Revenue Market Share by Country (2016-2021)
Table 75. Asia Pacific Human Interleukin-2 (IL-2) Sales by Region (2016-2021) & (KG)
Table 76. Asia Pacific Human Interleukin-2 (IL-2) Sales Market Share by Region (2016-2021)
Table 77. Asia Pacific Human Interleukin-2 (IL-2) Revenue by Region (2016-2021) & (US$ Million)
Table 78. Asia Pacific Human Interleukin-2 (IL-2) Revenue Market Share by Region (2016-2021)
Table 79. Europe Human Interleukin-2 (IL-2) Sales by Country (2016-2021) & (KG)
Table 80. Europe Human Interleukin-2 (IL-2) Sales Market Share by Country (2016-2021)
Table 81. Europe Human Interleukin-2 (IL-2) Revenue by Country (2016-2021) & (US$ Million)
Table 82. Europe Human Interleukin-2 (IL-2) Revenue Market Share by Country (2016-2021)
Table 83. Latin America Human Interleukin-2 (IL-2) Sales by Country (2016-2021) & (KG)
Table 84. Latin America Human Interleukin-2 (IL-2) Sales Market Share by Country (2016-2021)
Table 85. Latin Americaa Human Interleukin-2 (IL-2) Revenue by Country (2016-2021) & (US$ Million)
Table 86. Latin America Human Interleukin-2 (IL-2) Revenue Market Share by Country (2016-2021)
Table 87. Middle East and Africa Human Interleukin-2 (IL-2) Sales by Country (2016-2021) & (KG)
Table 88. Middle East and Africa Human Interleukin-2 (IL-2) Sales Market Share by Country (2016-2021)
Table 89. Middle East and Africa Human Interleukin-2 (IL-2) Revenue by Country (2016-2021) & (US$ Million)
Table 90. Middle East and Africa Human Interleukin-2 (IL-2) Revenue Market Share by Country (2016-2021)
Table 91. Roche Corporation Information
Table 92. Roche Description and Business Overview
Table 93. Roche Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 94. Roche Human Interleukin-2 (IL-2) Product
Table 95. Roche Recent Development
Table 96. BMS Corporation Information
Table 97. BMS Description and Business Overview
Table 98. BMS Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 99. BMS Product
Table 100. BMS Recent Development
Table 101. Schering-Plough Corporation Information
Table 102. Schering-Plough Description and Business Overview
Table 103. Schering-Plough Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 104. Schering-Plough Product
Table 105. Schering-Plough Recent Development
Table 106. AbbVie Inc Corporation Information
Table 107. AbbVie Inc Description and Business Overview
Table 108. AbbVie Inc Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 109. AbbVie Inc Product
Table 110. AbbVie Inc Recent Development
Table 111. Alkermes Plc Corporation Information
Table 112. Alkermes Plc Description and Business Overview
Table 113. Alkermes Plc Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 114. Alkermes Plc Product
Table 115. Alkermes Plc Recent Development
Table 116. APT Therapeutics Corporation Information
Table 117. APT Therapeutics Description and Business Overview
Table 118. APT Therapeutics Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 119. APT Therapeutics Product
Table 120. APT Therapeutics Recent Development
Table 121. Mabtech Limited Corporation Information
Table 122. Mabtech Limited Description and Business Overview
Table 123. Mabtech Limited Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 124. Mabtech Limited Product
Table 125. Mabtech Limited Recent Development
Table 126. Philogen Corporation Information
Table 127. Philogen Description and Business Overview
Table 128. Philogen Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 129. Philogen Product
Table 130. Philogen Recent Development
Table 131. Sinopharm Corporation Information
Table 132. Sinopharm Description and Business Overview
Table 133. Sinopharm Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 134. Sinopharm Product
Table 135. Sinopharm Recent Development
Table 136. Jiangsu Jinsili Pharmaceutical Corporation Information
Table 137. Jiangsu Jinsili Pharmaceutical Description and Business Overview
Table 138. Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 139. Jiangsu Jinsili Pharmaceutical Product
Table 140. Jiangsu Jinsili Pharmaceutical Recent Development
Table 141. Shenyang Sansheng Pharmaceutical Corporation Information
Table 142. Shenyang Sansheng Pharmaceutical Description and Business Overview
Table 143. Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 144. Shenyang Sansheng Pharmaceutical Product
Table 145. Shenyang Sansheng Pharmaceutical Recent Development
Table 146. Beijing Shuanglu Pharmaceutical Corporation Information
Table 147. Beijing Shuanglu Pharmaceutical Description and Business Overview
Table 148. Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 149. Beijing Shuanglu Pharmaceutical Product
Table 150. Beijing Shuanglu Pharmaceutical Recent Development
Table 151. Shandong Quangang Pharmaceutical Corporation Information
Table 152. Shandong Quangang Pharmaceutical Description and Business Overview
Table 153. Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 154. Shandong Quangang Pharmaceutical Product
Table 155. Shandong Quangang Pharmaceutical Recent Development
Table 156. Shanghai Huaxin Biological high-tech Corporation Information
Table 157. Shanghai Huaxin Biological high-tech Description and Business Overview
Table 158. Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 159. Shanghai Huaxin Biological high-tech Product
Table 160. Shanghai Huaxin Biological high-tech Recent Development
Table 161. Beijing Yuance Pharmaceutical Corporation Information
Table 162. Beijing Yuance Pharmaceutical Description and Business Overview
Table 163. Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 164. Beijing Yuance Pharmaceutical Product
Table 165. Beijing Yuance Pharmaceutical Recent Development
Table 166. Beijing Sihuan Biological Pharmaceutical Corporation Information
Table 167. Beijing Sihuan Biological Pharmaceutical Description and Business Overview
Table 168. Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 169. Beijing Sihuan Biological Pharmaceutical Product
Table 170. Beijing Sihuan Biological Pharmaceutical Recent Development
Table 171. Beijing Sanyuan Gene Pharmaceutical Corporation Information
Table 172. Beijing Sanyuan Gene Pharmaceutical Description and Business Overview
Table 173. Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 174. Beijing Sanyuan Gene Pharmaceutical Product
Table 175. Beijing Sanyuan Gene Pharmaceutical Recent Development
Table 176. Shenzhen Kexing Biological Engineering Corporation Information
Table 177. Shenzhen Kexing Biological Engineering Description and Business Overview
Table 178. Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 179. Shenzhen Kexing Biological Engineering Product
Table 180. Shenzhen Kexing Biological Engineering Recent Development
Table 181. Shanghai Sanwei Biotechnology Corporation Information
Table 182. Shanghai Sanwei Biotechnology Description and Business Overview
Table 183. Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 184. Shanghai Sanwei Biotechnology Product
Table 185. Shanghai Sanwei Biotechnology Recent Development
Table 186. Xiamen Tebao Biological Engineering Corporation Information
Table 187. Xiamen Tebao Biological Engineering Description and Business Overview
Table 188. Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 189. Xiamen Tebao Biological Engineering Product
Table 190. Xiamen Tebao Biological Engineering Recent Development
Table 191. Chengdu huashen Biotechnology Corporation Information
Table 192. Chengdu huashen Biotechnology Description and Business Overview
Table 193. Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 194. Chengdu huashen Biotechnology Product
Table 195. Chengdu huashen Biotechnology Recent Development
Table 196. Shanghai Pharma Group Corporation Information
Table 197. Shanghai Pharma Group Description and Business Overview
Table 198. Shanghai Pharma Group Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 199. Shanghai Pharma Group Product
Table 200. Shanghai Pharma Group Recent Development
Table 201. Guangdong Xinghao Pharmaceutical Corporation Information
Table 202. Guangdong Xinghao Pharmaceutical Description and Business Overview
Table 203. Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 204. Guangdong Xinghao Pharmaceutical Product
Table 205. Guangdong Xinghao Pharmaceutical Recent Development
Table 206. Human Interleukin-2 (IL-2) Market Trends
Table 207. Human Interleukin-2 (IL-2) Market Drivers
Table 208. Human Interleukin-2 (IL-2) Market Challenges
Table 209. Human Interleukin-2 (IL-2) Market Restraints
Table 210. Human Interleukin-2 (IL-2) Customers List
Table 211. Human Interleukin-2 (IL-2) Distributors List
Table 212. Research Programs/Design for This Report
Table 213. Key Data Information from Secondary Sources
Table 214. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Interleukin-2 (IL-2) Product Picture
Figure 2. Global Human Interleukin-2 (IL-2) Sales Market Share by Type in 2020 & 2027
Figure 3. 50000 U Product Picture
Figure 4. 100000 U Product Picture
Figure 5. 200000 U Product Picture
Figure 6. 500000 U Product Picture
Figure 7. 1 Million U Product Picture
Figure 8. 2 Million U Product Picture
Figure 9. Global Human Interleukin-2 (IL-2) Sales Market Share by Application in 2020 & 2027
Figure 10. Recombinant Interferon
Figure 11. Recombinant Interleukin
Figure 12. Natural Biological Products
Figure 13. Poison Immune
Figure 14. Gene Therapy
Figure 15. Monoclonal Antibody
Figure 16. Human Interleukin-2 (IL-2) Report Years Considered
Figure 17. Global Human Interleukin-2 (IL-2) Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Human Interleukin-2 (IL-2) Market Size 2016-2027 (US$ Million)
Figure 19. Global Human Interleukin-2 (IL-2) Sales 2016-2027 (KG)
Figure 20. Global Human Interleukin-2 (IL-2) Market Size Market Share by Region: 2021 Versus 2027
Figure 21. Global Human Interleukin-2 (IL-2) Sales Market Share by Region (2016-2021)
Figure 22. Global Human Interleukin-2 (IL-2) Sales Market Share by Region in 2020
Figure 23. Global Human Interleukin-2 (IL-2) Revenue Market Share by Region (2016-2021)
Figure 24. Global Human Interleukin-2 (IL-2) Revenue Market Share by Region in 2020
Figure 25. Global Human Interleukin-2 (IL-2) Sales Share by Manufacturer in 2020
Figure 26. The Top 10 and 5 Players Market Share by Human Interleukin-2 (IL-2) Revenue in 2020
Figure 27. Human Interleukin-2 (IL-2) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Human Interleukin-2 (IL-2) Sales Market Share by Type (2016-2021)
Figure 29. Global Human Interleukin-2 (IL-2) Sales Market Share by Type in 2020
Figure 30. Global Human Interleukin-2 (IL-2) Revenue Market Share by Type (2016-2021)
Figure 31. Global Human Interleukin-2 (IL-2) Revenue Market Share by Type in 2020
Figure 32. Global Human Interleukin-2 (IL-2) Sales Market Share by Application (2016-2021)
Figure 33. Global Human Interleukin-2 (IL-2) Sales Market Share by Application in 2020
Figure 34. Global Human Interleukin-2 (IL-2) Revenue Market Share by Application (2016-2021)
Figure 35. Global Human Interleukin-2 (IL-2) Revenue Market Share by Application in 2020
Figure 36. China Human Interleukin-2 (IL-2) Sales Growth Rate 2016-2027 (KG)
Figure 37. China Human Interleukin-2 (IL-2) Revenue Growth Rate 2016-2027 (US$ Million)
Figure 38. China Human Interleukin-2 (IL-2) Market Share in Global Market 2016-2027
Figure 39. China 5 and 10 Largest Human Interleukin-2 (IL-2) Players Market Share by Revenue in Human Interleukin-2 (IL-2) in 2020
Figure 40. China Human Interleukin-2 (IL-2) Revenue Share by Type (2016-2021)
Figure 41. China Human Interleukin-2 (IL-2) Revenue Growth Rate by Type in 2016 & 2020
Figure 42. China Human Interleukin-2 (IL-2) Revenue Share by Application (2016-2021)
Figure 43. China Human Interleukin-2 (IL-2) Revenue Growth Rate by Application in 2016 & 2020
Figure 44. North America Human Interleukin-2 (IL-2) Sales Growth Rate 2016-2021 (KG)
Figure 45. North America Human Interleukin-2 (IL-2) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. North America Human Interleukin-2 (IL-2) Sales Market Share by Country in 2020
Figure 47. North America Human Interleukin-2 (IL-2) Revenue Market Share by Country in 2020
Figure 48. U.S. Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 49. U.S. Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Canada Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 51. Canada Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. Europe Human Interleukin-2 (IL-2) Sales Growth Rate 2016-2021 (KG)
Figure 53. Europe Human Interleukin-2 (IL-2) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 54. Europe Human Interleukin-2 (IL-2) Sales Market Share by Country in 2020
Figure 55. Europe Human Interleukin-2 (IL-2) Revenue Market Share by Country in 2020
Figure 56. Germany Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 57. Germany Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. France Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 59. France Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. U.K. Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 61. U.K. Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Italy Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 63. Italy Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Russia Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 65. Russia Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Asia Pacific Human Interleukin-2 (IL-2) Sales Growth Rate 2016-2021 (KG)
Figure 67. Asia Pacific Human Interleukin-2 (IL-2) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 68. Asia Pacific Human Interleukin-2 (IL-2) Sales Market Share by Region in 2020
Figure 69. Asia Pacific Human Interleukin-2 (IL-2) Revenue Market Share by Region in 2020
Figure 70. China Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 71. China Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Japan Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 73. Japan Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. South Korea Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 75. South Korea Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. India Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 77. India Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Australia Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 79. Australia Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Taiwan Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 81. Taiwan Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Indonesia Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 83. Indonesia Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Thailand Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 85. Thailand Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Malaysia Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 87. Malaysia Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Philippines Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 89. Philippines Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Vietnam Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 91. Vietnam Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Latin America Human Interleukin-2 (IL-2) Sales Growth Rate 2016-2021 (KG)
Figure 93. Latin America Human Interleukin-2 (IL-2) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 94. Latin America Human Interleukin-2 (IL-2) Sales Market Share by Country in 2020
Figure 95. Latin America Human Interleukin-2 (IL-2) Revenue Market Share by Country in 2020
Figure 96. Mexico Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 97. Mexico Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. Brazil Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 99. Brazil Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Argentina Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 101. Argentina Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. Middle East and Africa Human Interleukin-2 (IL-2) Sales Growth Rate 2016-2021 (KG)
Figure 103. Middle East and Africa Human Interleukin-2 (IL-2) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 104. Middle East and Africa Human Interleukin-2 (IL-2) Sales Market Share by Country in 2020
Figure 105. Middle East and Africa Human Interleukin-2 (IL-2) Revenue Market Share by Country in 2020
Figure 106. Turkey Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 107. Turkey Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 108. Saudi Arabia Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 109. Saudi Arabia Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 110. UAE Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG)
Figure 111. UAE Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 112. Human Interleukin-2 (IL-2) Value Chain
Figure 113. Channels of Distribution
Figure 114. Distributors Profiles
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed
Keyplayers in Global and China Human Interleukin-2 (IL-2) Market Insights, Forecast to 2027
RocheBMS
Schering-Plough
AbbVie Inc
Alkermes Plc
APT Therapeutics
Mabtech Limited
Philogen
Sinopharm
Jiangsu Jinsili Pharmaceutical
Shenyang Sansheng Pharmaceutical
Beijing Shuanglu Pharmaceutical
Shandong Quangang Pharmaceutical
Shanghai Huaxin Biological high-tech
Beijing Yuance Pharmaceutical
Beijing Sihuan Biological Pharmaceutical
Beijing Sanyuan Gene Pharmaceutical
Shenzhen Kexing Biological Engineering
Shanghai Sanwei Biotechnology
Xiamen Tebao Biological Engineering
Chengdu huashen Biotechnology
Shanghai Pharma Group
Guangdong Xinghao Pharmaceutical
Request Sample
Request Discount
